SVRA (Savara) E10: $-1.87 (As of Mar. 2026)


SVRA Savara Inc SVRA
19 GF Score
Price $5.90
! 3 Warning Signs
View Full Analysis

What is Savara E10?

Savara SVRA -1.99% 19 E10 is $-1.87 as of Mar. 2026. GuruFocus rates SVRA with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Savara's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.87 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 35.40% per year. During the past 5 years, the average E10 Growth Rate was 28.90% per year. During the past 10 years, the average E10 Growth Rate was 38.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Savara was 54.20% per year. The lowest was 6.60% per year. And the median was 26.75% per year.

As of today (2026-06-27), Savara's current stock price is $5.895. Savara's E10 for the quarter that ended in Mar. 2026 was $-1.87. Savara's Shiller PE Ratio of today is .


Savara  (NAS:SVRA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Savara E10 Related Terms


Savara E10 Historical Data

* Premium members only.

The historical data trend for Savara's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Savara E10 Chart

Savara Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.29 -8.97 -6.45 -4.54 -2.42

Savara Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.04 -3.52 -2.98 -2.42 -1.87

SVRA vs ABSI, CRVS, JBIO: E10 Comparison

For the Biotechnology subindustry, Savara's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Savara Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Savara's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Savara's Shiller PE Ratio falls into.


SVRA
19GF Score
Savara Inc SVRA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Savara E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Savara's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.15/330.2130*330.2130
=-0.150

Current CPI (Mar. 2026) = 330.2130.

Savara Quarterly Data

per share eps CPI Adj_EPS
201606 -1.970 241.018 -2.699
201609 -1.210 241.428 -1.655
201612 -1.400 241.432 -1.915
201703 -1.650 243.801 -2.235
201706 -0.900 244.955 -1.213
201709 -0.280 246.819 -0.375
201712 -0.230 246.524 -0.308
201803 -0.860 249.554 -1.138
201806 -0.370 251.989 -0.485
201809 -0.360 252.439 -0.471
201812 -0.290 251.233 -0.381
201903 -0.340 254.202 -0.442
201906 -0.570 256.143 -0.735
201909 -0.300 256.759 -0.386
201912 -0.720 256.974 -0.925
202003 -0.270 258.115 -0.345
202006 -0.160 257.797 -0.205
202009 -0.180 260.280 -0.228
202012 -0.230 260.474 -0.292
202103 -0.130 264.877 -0.162
202106 -0.070 271.696 -0.085
202109 -0.070 274.310 -0.084
202112 -0.070 278.802 -0.083
202203 -0.050 287.504 -0.057
202206 -0.060 296.311 -0.067
202209 -0.070 296.808 -0.078
202212 -0.070 296.797 -0.078
202303 -0.070 301.836 -0.077
202306 -0.070 305.109 -0.076
202309 -0.100 307.789 -0.107
202312 -0.080 306.746 -0.086
202403 -0.110 312.332 -0.116
202406 -0.120 314.175 -0.126
202409 -0.110 315.301 -0.115
202412 -0.130 315.605 -0.136
202503 -0.120 319.799 -0.124
202506 -0.140 322.561 -0.143
202509 -0.140 324.800 -0.142
202512 -0.130 324.054 -0.132
202603 -0.150 330.213 -0.150

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-1.87 mean?
Savara (SVRA) has a E10 of $-1.87 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Savara and its competitors.
Is Savara's E10 too high?
Savara's current E10 is $-1.87. Overall, Savara has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Savara's E10 compare to ABSI and CRVS?
Savara's E10 of $-1.87 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Savara and its competitors. Savara's current E10 is $-1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savara stock overvalued right now?
Savara (SVRA) has a current E10 of $-1.87. The current E10 is $-1.87. Savara's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Savara (SVRA), the current E10 is $-1.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Savara Business Description

Other Exchanges YB4P:Germany
Address 1717 Langhorne Newtown Road, Suite 300, One Summit Square, Langhorne, PA, USA, 19047
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
19GF Score

Get the complete analysis for SVRA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.90
Price